Prior Authorization and Future Applications

This session reviews miscellaneous and future applications of radiopharmaceutical therapy, many of which are under development or in use outside of the U.S. Presenters discuss radiopharmaceutical applications such as meta-iodobenzylguanidine (MIBG) therapy, topical rhenium skin cancer therapy, radiosynoviorthesis, palliative radiopharmaceutical therapies, indications in hematologic malignancies, and the increasing role of alpha emitters in radiopharmaceutical therapies. Presenters also touch on how to become an authorized user for administration of radiopharmaceutical therapies.

Topics:

  • Miscellaneous and Future Applications of Radiopharmaceutical Therapy – How To Become an Authorized User, Meta-iodobenzylguanidine, Rhenium Skin Cancer Therapy, Radiosynoviorthesis, Alpha Emitters, Other - Michael Folkert, MD, PhD

Target Audience

This activity is designed to meet the interests of radiation oncologists, radiation physicists, radiation biologists and radiation oncology residents.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Identify novel applications of radiopharmaceutical therapies.
  • Increase awareness of future directions in radiopharmaceutical therapies.
  • Describe the process of becoming an authorized user.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
03/28/2024
Course expires: 
07/04/2026
Cost:
$0.00
Part of: 
Beyond the Beam: A Radiation Oncology Curriculum for Radiopharmaceutical Therapy
Rating: 
0
  • Michael Folkert, MD, PhD, is employed by Northwell Health. Dr. Folkert serves as Education Subcommittee Chair with the American Brachytherapy Society and is a radiation oncologist representative with the Advisory Committee on the Medical Uses of Isotopes. 

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.